Source:http://linkedlifedata.com/resource/pubmed/id/10771016
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-3
|
pubmed:dateCreated |
2000-8-11
|
pubmed:abstractText |
Human brain ageing is associated with reductions in a variety of nicotinic receptors subtypes, whereas changes in age-related disorders including Alzheimer's disease or Parkinson's disease are more selective. In Alzheimer's disease, in the cortex there is a selective loss of the alpha4 (but not alpha3 or 7) subunit immunoreactivity and of nicotine or epibatidine binding but not alpha-bungarotoxin binding. Epibatidine binding is inversely correlated with clinical dementia ratings and with the level of Abeta1-42, but not related to plaque or tangle densities. In contrast, alpha-bungarotoxin binding is positively correlated with plaque densities in the entorhinal cortex. In human temporal cortex loss of acetylcholinesterase catalytic activity is positively correlated with decreased epibatidine binding and in a transgenic mouse model over expressing acetylcholinesterase, epibatidine binding is elevated. In Parkinson's disease, loss of striatal nicotine binding appears to occur early but is not associated with a loss of alpha4 subunit immunoreactivity. Tobacco use in normal elderly individuals is associated with increased alpha4 immunoreactivity in the cortex and lower densities of amyloid-beta plaques, and with greater numbers of dopaminergic neurons in the substantia nigra pars compacta. These findings indicate an early involvement of the alpha4 subunit in beta-amyloidosis but not in nigro-striatal dopaminergic degeneration.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholinesterase,
http://linkedlifedata.com/resource/pubmed/chemical/Nicotine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Nicotinic,
http://linkedlifedata.com/resource/pubmed/chemical/alpha7 nicotinic acetylcholine...,
http://linkedlifedata.com/resource/pubmed/chemical/nicotinic receptor alpha3beta4
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0014-2999
|
pubmed:author |
pubmed-author:BallardCC,
pubmed-author:BuxbaumJ DJD,
pubmed-author:ClementiFF,
pubmed-author:CohenOO,
pubmed-author:CourtJJ,
pubmed-author:DavisKK,
pubmed-author:GottiCC,
pubmed-author:GriffithsMM,
pubmed-author:HaroutunianVV,
pubmed-author:JarosEE,
pubmed-author:JohnsonMM,
pubmed-author:LeaII,
pubmed-author:Martin-RuizCC,
pubmed-author:McKeithII,
pubmed-author:NãslandJJ,
pubmed-author:PerryEE,
pubmed-author:PerryRR,
pubmed-author:PiggottMM,
pubmed-author:SoreqHH,
pubmed-author:TzartosSS
|
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
393
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
215-22
|
pubmed:dateRevised |
2010-6-4
|
pubmed:meshHeading |
pubmed-meshheading:10771016-Acetylcholinesterase,
pubmed-meshheading:10771016-Aging,
pubmed-meshheading:10771016-Alzheimer Disease,
pubmed-meshheading:10771016-Analysis of Variance,
pubmed-meshheading:10771016-Animals,
pubmed-meshheading:10771016-Brain,
pubmed-meshheading:10771016-Humans,
pubmed-meshheading:10771016-Lewy Body Disease,
pubmed-meshheading:10771016-Mice,
pubmed-meshheading:10771016-Mice, Transgenic,
pubmed-meshheading:10771016-Nicotine,
pubmed-meshheading:10771016-Receptors, Nicotinic,
pubmed-meshheading:10771016-Smoking
|
pubmed:year |
2000
|
pubmed:articleTitle |
Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases.
|
pubmed:affiliation |
Department of Neuropathology, MRC Neurochemical Pathology Unit, Newcastle General Hospital, Westgate Road, Newcastle, UK. e.k.perry@ncl.ac.uk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|